Ilika raises £0.9m in upsized retail offer

Ilika plc

Further to the announcement by the Company in respect of the Retail Offer dated 22 May 2025, Ilika plc (LON:IKA), has announced that, following the closing of the Retail Offer on the BookBuild platform on 28 May 2025, the Retail Offer was significantly oversubscribed. Accordingly, the Company has elected to increase scale of the Retail Offer to raise total gross proceeds of £0.9 million through the issue of 2,727,273 Retail Offer Shares at the Issue Price of 33 pence per share.

Consequently, it is anticipated that 9,884,017 Placing Shares, 81,819 Director Subscription Shares and 2,727,273 Retail Offer Shares resulting in a total of 12,693,109 New Ordinary Shares being issued in relation to the Fundraising. The total gross monies raised (before expenses) is approximately £4.2 million. The proceeds will be used as outlined in the retail offer announcement dated 22 May 2025 with the excess being proportionately assigned to further advance the commercial status of both of the Company’s product lines.

Allocations were made to existing Shareholders, applying the principles of soft pre-emption.  Given the significant demand, existing Shareholders received 100 per cent. of their soft pre-emptive allowance, when their order matched or exceeded their soft pre-emptive allowance. Where the order was greater than the soft pre-emptive allowance shareholders received c. 89.97 per cent of their additional demand1.

Other than where defined, capitalised terms used in this announcement have the meanings given to them in the Retail Offer Announcement.

Total Voting Rights

Following Admission of the New Ordinary Shares, the Company will have 180,802,175 Ordinary Shares in issue with the Company holding no Ordinary Shares in treasury. Therefore, the total number of voting rights will also be 180,802,175. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Ilika Plc under the FCA’s Disclosure Guidance and Transparency Rules.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika Stereax batteries to feature at MEDevice Silicon Valley

Ilika will have its Stereax technology represented by Cirtec Medical at MEDevice Silicon Valley on 18 and 19 November 2026, providing further exposure to its medical device battery technology.

Ilika targets Europe’s next phase of solid-state battery development

Ilika is positioned around Europe’s push for next-generation solid-state batteries as manufacturers seek better performance and less dependence on Asian supply chains.

Ilika targets lighter EV battery packs

Ilika’s Goliath solid-state battery technology targets a higher cell-to-pack ratio by combining high-nickel NMC chemistry with a non-flammable solid electrolyte.

Ilika’s Graeme Purdy on Goliath, defence and Brompton progress (LON:IKA)

Ilika CEO Graeme Purdy discusses the completion of the PRIMED programme, improved consistency in Goliath battery performance, growing defence interest and progress with Brompton on e-bike battery applications.

Ilika appoints Robin Anderton-Brown as strategic defence advisor

Former UK Strategic Command Director of Capability Robin Anderton-Brown joins Ilika as a strategic advisor, supporting opportunities for its Goliath solid-state batteries in the defence sector.

Search